An experimental new weight loss drug may be even more powerful than the current GLP-1s options, such as Ozempic or Wegovy, and help users shed even more pounds.
Retatrutide, a highly anticipated new weight-loss drug, passed a critical late-stage trial in patients with obesity, drug maker Eli Lilly announced Thursday.